Gregory M. McKee

President & Chief Executive Officer
Nventa Biopharmaceuticals Corporation

Gregory McKee has served as our President and Chief Executive Officer since April 2005. Mr. McKee joined the Company in June 2003 serving as Vice President, Corporate Development & Strategic Planning. He became the Company's Chief Financial Officer in January 2004, and then became the Company's President and Chief Executive Officer and a director in April 2005. His previous experience includes work as Senior Director, Corporate Development for Valentis, Inc., a San Francisco based gene therapy company, from July 2000 through June 2003. From June 1996 through December 1999, Mr. McKee served in several management positions at Genzyme Corporation, a biotechnology company. Mr. McKee also spent five years in investment banking. Mr. McKee graduated with a B.A. degree in Economics from the University of Washington , an M.A. in International Studies from The Joseph H. Lauder Institute at the University of Pennsylvania and earned an MBA from the Wharton School .